Philippe Galera
Overview
Explore the profile of Philippe Galera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Terlinden A, Jacquet S, Manivong S, Cullier A, Casse F, Legendre F, et al.
BMC Vet Res
. 2024 Dec;
20(1):547.
PMID: 39633332
Background: Osteoarthritis is a leading cause of pain and retirement in athletic horses. Hydro-expansive functionalized nanogels, acting as Drug Delivery Systems, constitute one of the current therapeutic prospects. These nanogels...
2.
Rouge M, Legendre F, Elkhatib R, Delalande C, Cognie J, Reigner F, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069100
The castration of stallions is traditionally performed after puberty, at around the age of 2 years old. No studies have focused on the effects of early castration on osteoarticular metabolism....
3.
Jammes M, Casse F, Velot E, Bianchi A, Audigie F, Contentin R, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762473
Osteoarthritis (OA) is a widespread osteoarticular pathology characterized by progressive hyaline cartilage degradation, exposing horses to impaired well-being, premature career termination, alongside substantial financial losses for horse owners. Among the...
4.
Jammes M, Contentin R, Audigie F, Casse F, Galera P
Front Bioeng Biotechnol
. 2023 Sep;
11:1204737.
PMID: 37720315
Osteoarthritis (OA) is an invalidating articular disease characterized by cartilage degradation and inflammatory events. In horses, OA is associated with up to 60% of lameness and leads to reduced animal...
5.
Veys C, Boulouard F, Benmoussa A, Jammes M, Brotin E, Redini F, et al.
Front Oncol
. 2023 Sep;
13:1220459.
PMID: 37719019
Chondrosarcomas and osteosarcomas are malignant bone tumors with a poor prognosis when unresectable or metastasized. Moreover, radiotherapy and chemotherapy could be ineffective. MiRNAs represent an alternative therapeutic approach. Based on...
6.
Jammes M, Contentin R, Casse F, Galera P
Front Vet Sci
. 2023 Feb;
10:1115774.
PMID: 36846261
Osteoarthritis (OA) is a degenerative disease that eventually leads to the complete degradation of articular cartilage. Articular cartilage has limited intrinsic capacity for self-repair and, to date, there is no...
7.
Cullier A, Casse F, Manivong S, Contentin R, Legendre F, Garcia Ac A, et al.
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012214
Osteoarthritis (OA) is a degenerative and heterogeneous disease that affects all types of joint structures. Current clinical treatments are only symptomatic and do not manage the degenerative process in animals...
8.
Contentin R, Jammes M, Bourdon B, Casse F, Bianchi A, Audigie F, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628604
Equine osteoarthritis (OA) leads to cartilage degradation with impaired animal well-being, premature cessation of sport activity, and financial losses. Mesenchymal stem cell (MSC)-based therapies are promising for cartilage repair, but...
9.
Veys C, Jammes M, Redini F, Poulain L, Denoyelle C, Legendre F, et al.
Pharmaceuticals (Basel)
. 2022 Mar;
15(3).
PMID: 35337159
Osteosarcomas are the most common type of malignant bone tumor. These tumors are characterized by the synthesis of an osteoid matrix. Current treatments are based on surgery and combination chemotherapy....
10.
Rouge M, Elkhatib R, Delalande C, Cognie J, Reigner F, Barriere P, et al.
Domest Anim Endocrinol
. 2021 Nov;
79:106691.
PMID: 34844012
Although vitamin D acts in various biological processes, it plays a critical role in the maintenance of bone health, and regulates calcium homeostasis. In humans and rodents, the main tissues...